News Valbenazine May Improve Movement Disorders in Patients With Mood Disorders 1 year ago administrator An analysis of once-daily valbenazine trials revealed improvements in tardive dyskinesia in patients with mood disorders. Keith Ablow administrator See author's posts Tags: Keith Ablow Continue Reading Previous Risk for Depression and Suicidal Ideation Elevated Among Patients With Atopic DermatitisNext How Should Clinicians Discuss Prognosis With Patients?
